LYRA vs SQ
Lyra Therapeutics Inc (LYRA) versus SQ (SQ) — a side-by-side from cached financials, not a winner call.
Lyra Therapeutics Inc (LYRA) is a biotechnology company listed on US.
SQ (SQ) common stock.
Latest reported LYRA revenue for 2024-12-31 was $1.5M. Net income was -$93.4M. Revenue was down 1.5% from 2023-12-31 to 2024-12-31. LYRA currently screens at market cap $14.4M.
SQ does not have a complete income-statement cache yet.
LYRA currently screens at market cap $14.4M.
Not investment advice. Open the LYRA and SQ stock pages for the full models.
Not investment advice.